Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does HYDROCHLOROTHIAZIDE Cause Dysarthria? 102 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 102 reports of Dysarthria have been filed in association with HYDROCHLOROTHIAZIDE (Irbesartan and Hydrochlorothiazide). This represents 0.5% of all adverse event reports for HYDROCHLOROTHIAZIDE.

102
Reports of Dysarthria with HYDROCHLOROTHIAZIDE
0.5%
of all HYDROCHLOROTHIAZIDE reports
6
Deaths
89
Hospitalizations

How Dangerous Is Dysarthria From HYDROCHLOROTHIAZIDE?

Of the 102 reports, 6 (5.9%) resulted in death, 89 (87.3%) required hospitalization, and 10 (9.8%) were considered life-threatening.

Is Dysarthria Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HYDROCHLOROTHIAZIDE. However, 102 reports have been filed with the FAERS database.

What Other Side Effects Does HYDROCHLOROTHIAZIDE Cause?

Hyponatraemia (2,138) Drug ineffective (1,889) Acute kidney injury (1,838) Nausea (1,536) Dyspnoea (1,521) Dizziness (1,469) Headache (1,419) Hypotension (1,347) Fall (1,323) Malaise (1,312)

What Other Drugs Cause Dysarthria?

OLANZAPINE (900) QUETIAPINE (669) PREGABALIN (618) AMLODIPINE (553) GABAPENTIN (548) METFORMIN (540) METHOTREXATE (536) DIAZEPAM (512) ASPIRIN (495) LORAZEPAM (483)

Which HYDROCHLOROTHIAZIDE Alternatives Have Lower Dysarthria Risk?

HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\IRBESARTAN HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\LISINOPRIL HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\LOSARTAN HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\METOPROLOL HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\NEBIVOLOL

Related Pages

HYDROCHLOROTHIAZIDE Full Profile All Dysarthria Reports All Drugs Causing Dysarthria HYDROCHLOROTHIAZIDE Demographics